Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Soper

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Cancer Research|July 1, 1990
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancerA Berchuck, A Kamel, R Whitaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer SocietyE. I. Kohorn, D. P. Goldstein, B. W. Hancock, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Cancer Research|January 25, 1991
Coexpression of different antigenic markers on moieties that bear CA 125 determinantsY H Yu, D M Schlossman, C L Harrison, et al.
Cancer Research|April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potentialA Berchuck, A P Soisson, D L Clarke-Pearson, et al.
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Cancer Research|October 1, 1986
Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibodyD A Budwit-Novotny, K S McCarty, E B Cox, et al.
Gynecologic Oncology|March 31, 2000
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinomaF D Cirisano, S J Robboy, R K Dodge, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Cancer Research|July 1, 1990
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancerA Berchuck, A Kamel, R Whitaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology GroupJ T Thigpen, M F Brady, R D Alvarez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer SocietyE. I. Kohorn, D. P. Goldstein, B. W. Hancock, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Cancer Research|January 25, 1991
Coexpression of different antigenic markers on moieties that bear CA 125 determinantsY H Yu, D M Schlossman, C L Harrison, et al.
Cancer Research|April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potentialA Berchuck, A P Soisson, D L Clarke-Pearson, et al.
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Cancer Research|October 1, 1986
Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibodyD A Budwit-Novotny, K S McCarty, E B Cox, et al.
Gynecologic Oncology|March 31, 2000
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinomaF D Cirisano, S J Robboy, R K Dodge, et al.
Pageof 13